A patient with recurrent multifocal glioblastoma received chimeric antigen receptor (CAR)–engineered T cells targeting the tumor-associated antigen interleukin-13 receptor alpha 2 (IL13Rα2). Multiple ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback